Workout
Healthy Eating
Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process
Contact Us
Health Tracker
AI Tools
✔Fact Checked

Barcelona makes the sale of VIP seats at the Camp Nou official

Barcelona has officially announced the sale of the license for 475 VIP seats for the next 30 years, a product that will be available once the renovated Camp Nou reopens. It is believed that the value of the operation will be around 100-110 million euros.

President Joan Laporta had explained the agreement on Tuesday, and on Thursday the club confirmed that the two investors would have access to the use of the seats for 30 years and the possibility of selling their use themselves. As happened during Laporta’s press conference, the names of the investors remain uncertain, and the club did not specify what their value was, although it did point out that the documentation for the operation arrived before December 31, which in its opinion allowed Dani Olmo and Pau Víctor to register. They say it will also help pay off the debt for the Camp Nou renovation works.

Previously, the Institutional Vice President, Elena Fort, had confirmed that she did not know the names of the entities that had made the purchases either. In its announcement, Barcelona refers to them only as “Middle Eastern investors.” This lack of transparency has been harshly criticized by Laporta’s rivals, while LaLiga has explained that they do not consider that the documentation was in time to register Olmo and Víctor.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.